Inventor · disambiguated record
Alexandre Gross
Also filed as: GROSS ALEXANDRE · GROSS ALEXANDRE DAVID
12 granted patents·3 pending applications·100 citations·filing 2001–2024
90Inventor score
Files withCELGENE CAR LLC7AVENTIS PHARMA INC4GENZYME CORP2CELGENE AVILOMICS RES INC1INST NAT SANTE RECH MED1
Top patents by PatentIndex Score
15 records- 0192US9321786B2Heteroaryl compounds and uses thereofCELGENE AVILOMICS RES INC·Filed 2014·Granted Apr 26, 2016·15 cites·51 claims
- 0288US9663524B2Substituted pyrido[2,3-d]pyrimidines as protein kinase inhibitorsCELGENE CAR LLC·Filed 2014·Granted May 30, 2017·15 cites·27 claims
- 0387US9695132B2Heteroaryl compounds and uses thereofCELGENE CAR LLC·Filed 2016·Granted Jul 4, 2017·5 cites·63 claims
- 0487US7326792B2Heterocyclic compounds as P2X7 ion channel blockersAVENTIS PHARMA INC·Filed 2004·Granted Feb 5, 2008·29 cites·26 claims
- 0585US7741493B2Heterocyclic compounds as P2X7 ion channel blockersAVENTIS PHARMA INC·Filed 2007·Granted Jun 22, 2010·8 cites·10 claims
- 0680US10189794B2Heteroaryl compounds and uses thereofCELGENE CAR LLC·Filed 2017·Granted Jan 29, 2019·2 cites·56 claims
- 0780US7169925B2Indole derivatives as interleukin-4 gene expression inhibitorsAVENTIS PHARMA INC·Filed 2003·Granted Jan 30, 2007·14 cites·11 claims
- 0877US10065966B2Substituted pyrido[2,3-d]pyrimidines as inhibitors of protein kinasesCELGENE CAR LLC·Filed 2017·Granted Sep 4, 2018·2 cites·27 claims
- 0971US10774052B2Heteroaryl compounds and uses thereofCELGENE CAR LLC·Filed 2019·Granted Sep 15, 2020·0 cites·31 claims
- 1071US2022332687A1Heteroaryl compounds and uses thereofCELGENE CAR LLC·Filed 2020·Application pending·0 cites
- 1169US7541368B2Pyrazoles as inhibitors of tumor necrosis factorAVENTIS PHARMA INC·Filed 2005·Granted Jun 2, 2009·1 cites·24 claims
- 1267US7425606B2Method for screening peptides for use in immunotherapyINST NAT SANTE RECH MED·Filed 2001·Granted Sep 16, 2008·9 cites·7 claims
- 1365US2024279220A1Indole compounds and methods of useGENZYME CORP·Filed 2024·Application pending·0 cites
- 1464US2024239784A1Indole compounds and methods of useGENZYME CORP·Filed 2024·Application pending·0 cites
- 1562US10618902B2Substituted pyrido[2,3-d]pyrimidines as inhibitors of protein kinasesCELGENE CAR LLC·Filed 2018·Granted Apr 14, 2020·0 cites·15 claims
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →